68Ga-NODAGA-E(cRGDyK)2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-NODAGA-E(cRGDyK)2, covering 2016-11-22 to 2016-11-22. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans [Phase 1]